Sen. Burr on FDA User Fee Agreements: Innovation is Key, When FDA Does Not Live Up to Commitments, Patients Suffer
April 06, 2022
April 06, 2022
WASHINGTON, April 6 -- Sen. Richard Burr, R-North Carolina, ranking member of the Senate Health, Education, Labor and Pensions Committee, issued the following news release on April 5, 2022:
The Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing titled, "FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients." This is the Committee's first hearing to examine the commitment letters submitted . . .
The Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing titled, "FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients." This is the Committee's first hearing to examine the commitment letters submitted . . .